Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma

Histopathology

Volumn 52, Issue 3, 2008, Pages 277-282

  Mai, K T ^a,b   Teo, I ^b   Belanger, E C ^a,b   Robertson, S J ^a,b   Marginean, E C ^a,b   Islam, S ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Carcinoma; Kidney; Oncocytoma; Progesterone receptor

Indexed keywords

PROGESTERONE RECEPTOR; STEM CELL FACTOR RECEPTOR;

ADULT; ARTICLE; CANCER DIAGNOSIS; CLEAR CELL CARCINOMA; CYTOPLASM; DIAGNOSTIC VALUE; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; ONCOCYTOMA; PRIORITY JOURNAL;

ADENOMA, OXYPHILIC; CARCINOMA, RENAL CELL; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MALE; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 38849123230     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02931.x     Document Type: Article

References (42)

1. Li JJ, Weroha SJ, Davis MF, Tawfik O, Hou X, Li SA. ER and PR in renomedullary interstitial cells during Syrian hamster estrogen-induced tumorigenesis: evidence for receptor-mediated oncogenesis. Endocrinology 2001 142 4006 4014.
2. Bhat HK, Hacker HJ, Bannasch P, Thompson EA, Liehr JG. Localization of estrogen receptors in interstitial cells of hamster kidney and in estradiol-induced renal tumors as evidence of the mesenchymal origin of this neoplasm. Cancer Res. 1993 53 5447 5451.
3. Potier M, Elliot SJ, Tack I et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J. Am. Soc. Nephrol. 2001 12 241 251.
4. Neugarten J, Acharya A, Lei J, Silbiger S. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am. J. Physiol. Renal Physiol. 2000 279 F309 F318.
5. Silbiger S, Lei J, Ziyadeh FN, Neugarten J. Estradiol reverses TGF-beta1-stimulated type IV collagen gene transcription in murine mesangial cells. Am. J. Physiol. 1998 274 F1113 1118.
6. Michal M, Hes O, Bisceglia M et al. Mixed epithelial and stromal tumors of the kidney. A report of 22 cases. Virchows Arch. 2004 445 359 367.
7. Adsay NV, Eble JN, Srigley JR et al. Mixed epithelial and stromal tumor of the kidney. Am. J. Surg. Pathol. 2001 24 958 970.
8. Antic T, Perry KT, Harrison K et al. Mixed epithelial and stromal tumor of the kidney and cystic nephroma share overlapping features: reappraisal of 15 lesions. Arch. Pathol. Lab. Med. 2006 130 80 85.
9. Chatelain D, De Pinieux G, Kapfer J, Le Charpentier M, Viellefond A. Renal angiomyolipoma with predominant muscular epithelioid components. 2 cases. Ann. Pathol. 2000 20 150 153 (Article in French).
10. Cho NH, Shim HS, Choi YD, Kim DS. Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: a clinicopathological and immunohistochemical study of 67 cases. Pathol. Int. 2004 54 510 515.
11. Mai KT, Elkeilani A, Veinot JP. Mixed epithelial and stromal tumour (MEST) of the kidney: report of 14 cases with male and PEComatous variants and proposed histopathogenesis. Pathology 2007 39 235 240.
12. Jakse G, Muller-Holzner E. Hormone receptors in renal cancer: an overview. Semin. Surg. Oncol. 1988 4 161 164 (Review).
13. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R. Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors. J. Urol. 2004 171 (2 Pt 1 611 614.
14. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur. Urol. 2006 49 798 805.
15. Gustafsson JA. Estrogen receptor beta - a new dimension in estrogen mechanism of action. J. Endocrinol. 1999 163 379 383.
16. Arnett-Mansfield RL, DeFazio A, Mote PA, Clarke CL. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium. J. Clin. Endocrinol. Metab. 2004 89 1429 1442.
17. Michal M, Hes O, Bisceglia M et al. Mixed epithelial and stromal tumors of the kidney. A report of 22 cases. Virchows Arch. 2004 45 359 367.
18. Turbiner J, Amin MB, Humphrey PA et al. Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am. J. Surg. Pathol. 2007 3 489 500.
19. Henske EP, Ao X, Short MP et al. Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas. Mod. Pathol. 1998 11 665 668.
20. McDonald MW, Diokno AC, Seski JC, Menon KM. Measurement of progesterone receptor in human renal cell carcinoma and normal renal tissue. J. Surg. Oncol. 1983 22 164 166.
21. Concolino G, Di Silverio F, Marocchi A, Bracci U. Renal cancer steroid receptors: biochemical basis for endocrine therapy. Eur. Urol. 1979 5 319 322.
22. Bojar H, Maar K, Staib W. The endocrine background of human renal cell carcinoma: II. Attempt to induce the R-5020-binding components by oestrogens. Urol. Int. 1979 34 312 319.
23. Kruger S, Sotlar K, Kausch I, Horny HP. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma. Oncology 2005 68 269 275.
24. Lee H, Douglas-Jones AG, Morgan JM, Jasani B. The effect of fixation and processing on the sensitivity of oestrogen receptor assay by immunohistochemistry in breast carcinoma. J. Clin. Pathol. 2002 55 236 238.
25. Liu L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch. Pathol. Lab. Med. 2007 131 1290 1297.
26. Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod. Pathol. 2005 18 535 540.
27. Goldstein NS, Ferkowicz M, Odish E, Mani A, Hastah F. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am. J. Clin. Pathol. 2003 120 86 92.
28. Kato N, Honma K, Hojo H, Sasou S, Matsuzaki O, Motoyama T. KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis. Pathol. Int. 2005 55 4794 4783.
29. Wang HY, Mills SE. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Am. J. Surg. Pathol. 2005 29 640 646.
30. Huo L, Sugimura J, Tretiakova MS et al. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum. Pathol. 2005 36 262 268.
31. Li G, Gentil-Perret A, Lambert C, Genin C, Tostain J. S100A1 and KIT gene expressions in common subtypes of renal tumours. Eur. J. Surg. Oncol. 2005 31 299 303.
32. Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am. J. Clin. Pathol. 2004 121 878 883.
33. Miliaras D, Karasavvidou F, Papanikolaou A, Sioutopoulou D. KIT expression in fetal, normal adult, and neoplastic renal tissues. J. Clin. Pathol. 2004 57 463 466.
34. Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am. J. Surg. Pathol. 2004 28 676 678.
35. Memeo L, Jhang J, Assaad AM et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Am. J. Clin. Pathol. 2007 127 225 229.
36. Daniel L, Lechevallier E, Giorgi R et al. Pax-2 expression in adult renal tumors. Hum. Pathol. 2001 32 282 287.
37. Molinie V, Balaton A, Rotman S et al. Alpha-methyl CoA racemase expression in renal cell carcinomas. Hum. Pathol. 2006 37 698 703.
38. Mete O, Kilicaslan I, Gulluoglu MG, Uysal V. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch. 2005 447 938 946.
39. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000 24 203 210.
40. Al-Saleem T, Cairns P, Dulaimi EA, Feder M, Testa JR, Uzzo RG. The genetics of renal oncocytosis: a possible model for neoplastic progression. Cancer Genet. Cytogenet. 2004 152 23 28.
41. Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J. Urol. 2003 170 (Pt 1 2163 2172 (Review).
42. Tickoo SK, Reuter VE, Amin MB et al. Renal oncocytosis: a morphologic study of fourteen cases. Am. J. Surg. Pathol. 1999 23 1094 1101.